Should You Buy Healthy Extracts Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Healthy Extracts Inc. (HYEX) scores 4.9/10 on our Quality of Company framework, indicating mixed operational fundamentals. At the current price of $1.17, our multi-model valuation analyzes whether the market has already discounted these weaknesses.
The short answer: 0 of 5 CirclFi valuation models project upside for Healthy Extracts Inc. (HYEX) at $1.17 — the model consensus leans bearish, with a Quality Score of 4.9/10 and Value-Trap risk of 38/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Healthy Extracts Inc. (HYEX) in 2026?
What Is the Bull Case vs the Bear Case for Healthy Extracts Inc. (HYEX)?
| Bull case | Bear case — $0.02 target (-98.6%) |
|---|---|
| No active model projects meaningful upside for HYEX at $1.17. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | According to the CirclFi Quality of Company (QOC) framework, Healthy Extracts Inc.'s score of 4.9/10 signals fundamental weaknesses that could undermine the investment thesis. |
| According to the CirclFi Deep Alpha Valuation Engine, the Bayesian DCF model sees the stock as overvalued with a fair value of $0.02 (-98.6%), suggesting that the market price embeds overly optimistic growth assumptions. | |
| According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +92.2% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. | |
| Industry headwind: clinical trial failure represents a meaningful risk for Healthy Extracts Inc. and its Drug Manufacturers - Specialty & Generic peers. |
How Does HYEX Compare to Its Drug Manufacturers - Specialty & Generic Peers?
Valuation data pages: APUS · RGC · CANN · OWPC · IXHL · BTAI · BGM · SUPN · INCR · UTHR · AMPH
See full Drug Manufacturers - Specialty & Generic rankings →
Which Other Stocks Score Like HYEX on Quality?
Closest companies to HYEX’s Quality of Company score of 4.9/10, across all industries.
- FUSE — Fusemachines Inc. (QOC 4.9) · analysis
- HMR — Heidmar Maritime Holdings Corp. (QOC 4.9) · analysis
- MGAM — Mobile Global Esports Inc. (QOC 4.9) · analysis
- HQH — Abrdn Healthcare Investors (QOC 4.9) · analysis
- AMBQ — Ambiq Micro, Inc. (QOC 4.9) · analysis
- BOE — BlackRock Enhanced Global Dividend Trust (QOC 4.9) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Drug Manufacturers - Specialty & Generic Screens Does HYEX Appear In?
So Is Healthy Extracts Inc. (HYEX) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Healthy Extracts Inc. at $1.17. 5/5 models flag overvaluation, median fair value sits at $0.32 (-72.5%), and the risk-reward profile appears unfavorable. Quality at 4.9/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Healthy Extracts Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About HYEX Stock?
Should I buy HYEX stock right now?
Based on CirclFi's multi-model analysis, 0 of 5 models see upside for HYEX at $1.17. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Healthy Extracts Inc.?
Key risks include: a below-average Quality Score of 4.9/10, indicating fundamental weakness; limited model coverage (5/13 active), reducing analytical confidence; wide model disagreement (6469% spread), signaling high uncertainty; general market and sector-specific risks affecting Drug Manufacturers - Specialty & Generic companies. Always diversify and consult a financial advisor.
How does HYEX compare to its competitors?
Among Drug Manufacturers - Specialty & Generic peers, HYEX holds a Quality Score of 4.9/10. Comparable companies include APUS (QOC 5.0), RGC (QOC 4.8), CANN (QOC 5.1). The relative ranking helps investors identify whether HYEX offers better fundamental quality than alternatives in the same sector.
Is HYEX a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. HYEX's Quality Score of 4.9/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy HYEX at?
CirclFi does not provide target buy prices or price alerts. However, our 5 active models produce fair value estimates ranging from $0.02 to $1.10. At $1.17, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for HYEX.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad